Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | Conivaptan | [1] Conivaptan Conivaptan (Conivaptan) | [1] Conivaptan
Conivaptan
(Conivaptan) 💬
| [2] AVPR1A AVPR1A,AVPR2 💬 | [5] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬 | [1] 86 86 💬
|
| 2 | Spironolactone and conivaptan | [2] Conivaptan Conivaptan (Conivaptan),Spironolactone | [2] Spironolactone
Spironolactone
,Conivaptan (Conivaptan) 💬 | [3] AVPR1A AVPR1A,AVPR2, NR3C2 💬 | [6] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬 | [1] 86 86 💬
|